Palliative surgical treatment in patients with breast cancer

Last many years breast cancer on a leading position in the structure of oncological pathology among the female population. Patients with metastatic breast cancer, as well as with the presence of tumors with incipient decay or bleeding, are currently considered as patients for complex palliative systemic treatment. The question of the expediency of performing an operation in such a pathology occurs quite often in the daily practice of an oncologist-surgeon. Of course, such life-threatening conditions as decaying breast tumors, bleeding from them, do not raise doubts about the urgency of providing palliative surgical treatment, which is often it is sanitation mastectomy. However, the need for a surgical stage of treatment in the complex palliative therapy of metastatic breast cancer raises many questions. The possibilities of treating metastatic breast cancer have expanded significantly due to the development of drug therapy regimens, up to treating it as a chronic disease. The success of drug breast cancer treatment gives a chance to prolong the life of patients for many years. Thus, in the process of long-term treatment of these patients, various situations arise that require an individual solution. Based on the results of studies, the authors conclude that the decision to remove the primary breast lesion in such patients should be individualized and based on the opinion of the oncologist-surgeon, chemotherapist and radiation therapist, taking into account the potential risk, as well as the subsequent quality of life. In addition, as it turned out, the surgical stage of treatment in such patients not only improves the subsequent quality of life, but also improves oncological indicators. This article discusses the indications and contraindications for performing palliative surgical treatment of patients with breast cancer, based on world studies and our own experience and a clinical study.

1. Kaprin A. D., Starinsky V. V. Morbidity and mortality in 2019. M., 2020.

2. Zikiryakhodzhaev A. D., Shirokikh I. M., Ablitsova N. V., Ermoshchenkova M. V., Khakimova Sh.G., Khakimova G. G., Tukmakov A. Yu. Simultaneous breast reconstruction and postoperative radiation therapy: development of capsular contracture. Oncology Issues. 2019; 65 (3): 374–385.

3. Sukhotko A. S. Palliative mastectomies in the complex treatment of patients with breast cancer: Abstract. … PhD Med. Sciences: 14.00.12. Sukhotko Anna Sergeevna. M., 2014.

4. Kuznetsov A.V., Laktionov K.P., Portnoy S.M., Verigina O.S. Possibilities of surgical removal of the primary lesion in the treatment of patients with disseminated breast cancer. Bulletin of the Russian Research Center named after. N. N. Blokhin RAMS. 2010; 21(1):13.

5. Petrelli F, Barni S. Surgery of primary tumors in stage IV breast cancer: An updated meta-analysis of published studies with meta-regression. Medical Oncology. 2012; 29 (5): 3282–90.

6. Harris E, Barry M, Kell MR. Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival. Annals of Surgical Oncology. 2013; 20 (9): 2828–34.

7. Chia SK, Speers CH, D’yachkova Y et al. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer, 2007, 110: 973–9.

8. Rahman ZU, Frye DK, Smith TL et al. Results and long-term follow-up for 1581 patients with metastatic carcinoma treated with standard dose doxorubicincontaining chemotherapy. Cancer, 1999, 85: 104–11.

9. Bozhok A. A., Topuzov E. E., Zikiryakhodzhaev A. D., Sukhotko A. S., Khailenko V. A., Shatova Yu.S., Klimov N. A., Paltuev R. M. Evaluation of the results of the ROOM research project ‘Possibilities of surgical treatment of patients with stage IV breast cancer’. Tumors of the Female Reproductive System, 2016, 12 (4): 17–24. DOI:10.17650/1994–4098–2016–12–4–17–24.

10. Tosello G, Torloni MR, Mota BS, Neeman T, Riera R. Breast surgery for metastatic breast cancer. Cochrane Database of Systematic Reviews. 2018; 3. Art. No.: CD 011276.

11. Khan S. A., Stewart A. K., Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002; 132: 620–626.